ES2063383T3 - Vacunas contra la coccidiosis. - Google Patents
Vacunas contra la coccidiosis.Info
- Publication number
- ES2063383T3 ES2063383T3 ES91100502T ES91100502T ES2063383T3 ES 2063383 T3 ES2063383 T3 ES 2063383T3 ES 91100502 T ES91100502 T ES 91100502T ES 91100502 T ES91100502 T ES 91100502T ES 2063383 T3 ES2063383 T3 ES 2063383T3
- Authority
- ES
- Spain
- Prior art keywords
- proteins
- surface antigen
- dna
- protein
- fragos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000003495 Coccidiosis Diseases 0.000 title abstract 2
- 206010023076 Isosporiasis Diseases 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 101710203310 Apical membrane antigen 1 Proteins 0.000 abstract 2
- 241000223924 Eimeria Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 241000700618 Vaccinia virus Species 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 244000005700 microbiome Species 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
- 239000013603 viral vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/455—Eimeria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
ESTA INVENCION DE CODIFICACION DE DNA PARA UN PRECURSOR A UN ANTIGENO DE SUPERFICIE EIMERIA MEROZOITO, TENIENDO ESTE ANTIGENO DE SUPERFICIE UN PESO MOLECULAR APARENTE DE ALREDEDOR DE 23 KILODALTON POR SDS PAGE. BASADO EN LAS PROTEINAS DE ESTE DNA TENIENDO UNO O MAS DETERMINANTES INMUNOREACTIVOS Y/O ANTIGENICOS DE EL DICHO ANTIGENO DE SUPERFICIE QUE PUEDEN SER PREPARADOS, AL IGUAL QUE VECTORES O VIRUS RECOMBINANTES CONTENIENDO EL DICHO DNA O FRAGMENTOS DEL MISMO Y MICROORGANISMOS TRANSFORMADOS CONTENIENDO DICHOS VECTORES Y VIRUS. ASI, LA PRESENTE INVENCION TRATA TAMBIEN DE METODOS PARA LA PRODUCCION DE LAS DICHAS PROTEINAS Y MICROORGANISMOS TRANSFORMADOS. EL PRESENTE CASO TRATA TAMBIEN DE LA PURIFICACION DEL ANTIGENO DE SUPERFICIE MEROZOITO 23 KDA Y DE LA FORMA PRECURSORA 30 KDA DE ALLI PER SE Y DE METODOS PARA PROTECCION DE LOS POLLOS CONTRA COCCIDIOSIS UTILIZANDO EL ANTIGENO DE SUPERFICIE EIMERIA, LA PROTEINA PRECURSORA Y/O FRAGMENTOS DE ALLI. LAS PROTEINAS Y FRAGMENTOS DE ESTA INVENCION PUEDEN SER ADMINISTRADAS PARA TAL PROTECCION BIEN COMO PROTEINAS PURIFICADAS O EN FORMA DE DNA ENCODIFICANDO LA PROTEINA EN UN VECTOR VIRAL APROPIADO COMO ES EL VIRUS VACCINIA.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47050890A | 1990-01-26 | 1990-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2063383T3 true ES2063383T3 (es) | 1995-01-01 |
Family
ID=23867879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91100502T Expired - Lifetime ES2063383T3 (es) | 1990-01-26 | 1991-01-17 | Vacunas contra la coccidiosis. |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0439056B1 (es) |
JP (2) | JP3023997B2 (es) |
KR (2) | KR100197455B1 (es) |
AT (1) | ATE104349T1 (es) |
AU (1) | AU634335B2 (es) |
CA (1) | CA2034768A1 (es) |
DE (1) | DE69101646T2 (es) |
DK (1) | DK0439056T3 (es) |
ES (1) | ES2063383T3 (es) |
FI (1) | FI910398A (es) |
HR (1) | HRP930512B1 (es) |
HU (1) | HU211205B (es) |
IE (1) | IE65363B1 (es) |
IL (1) | IL97013A (es) |
MC (1) | MC2227A1 (es) |
NO (1) | NO303910B1 (es) |
NZ (1) | NZ236864A (es) |
PT (1) | PT96581B (es) |
SA (1) | SA91110265B1 (es) |
YU (1) | YU48525B (es) |
ZA (1) | ZA9010461B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5403581A (en) * | 1991-07-12 | 1995-04-04 | Hoffmann-La Roche Inc. | Coccidiosis vaccines |
US6008342A (en) * | 1991-07-12 | 1999-12-28 | Roche Vitamins Inc. | DNA encoding eimeria antigen |
EP0653489B1 (en) * | 1993-11-12 | 2003-02-19 | Akzo Nobel N.V. | Coccidiosis poultry vaccin |
DK0831896T3 (da) | 1995-06-07 | 2001-09-03 | Pfizer | In ovo-vaccination mod coccidiosis |
SK282004B6 (sk) | 1995-06-07 | 2001-10-08 | Pfizer Inc. | Použitie živých sporozoitov alebo merozoitov rodu eimeria na výrobu očkovacej látky na in ovo očkovanie domestikovaných vtákov proti kokcidióze |
EP0872486A1 (en) * | 1997-04-09 | 1998-10-21 | Akzo Nobel N.V. | Eimeria proteins as vaccines |
US6627205B2 (en) | 1997-12-01 | 2003-09-30 | Pfizer Incorporated | Ovo vaccination against coccidiosis |
US6680061B1 (en) | 1998-10-07 | 2004-01-20 | Theodorus Cornelis Schaap | Coccidiosis vaccines |
US6984378B1 (en) | 1999-02-26 | 2006-01-10 | Pfizer, Inc. | Method for the purification, recovery, and sporulation of cysts and oocysts |
DE60237977D1 (de) | 2001-08-30 | 2010-11-25 | Embrex Inc | Verbesserte verfahren zur herstellung von oozysten |
JP3995541B2 (ja) * | 2002-06-28 | 2007-10-24 | 株式会社ゲン・コーポレーション | 抗鶏コクシジウム症組成物 |
WO2004063339A2 (en) | 2003-01-08 | 2004-07-29 | Lesley Davenport | G-quadruplex binding assays and compounds therefor |
KR100628023B1 (ko) | 2004-06-11 | 2006-09-26 | (주)넥스젠 | 콕시듐 원충의 포자소체의 재조합 표면항원 단백질 및이를 포함하는 콕시듐병 백신 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0135073A3 (en) * | 1983-08-19 | 1987-05-27 | American Cyanamid Company | Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
CA1340520C (en) * | 1984-06-05 | 1999-05-04 | Karel Z. Newman Jr. | Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix |
ZA893740B (en) * | 1988-06-03 | 1990-02-28 | Hoffmann La Roche | Recombinant coccidiosis vaccines |
-
1990
- 1990-12-28 ZA ZA9010461A patent/ZA9010461B/xx unknown
-
1991
- 1991-01-17 DE DE69101646T patent/DE69101646T2/de not_active Expired - Fee Related
- 1991-01-17 ES ES91100502T patent/ES2063383T3/es not_active Expired - Lifetime
- 1991-01-17 EP EP91100502A patent/EP0439056B1/en not_active Expired - Lifetime
- 1991-01-17 DK DK91100502.3T patent/DK0439056T3/da active
- 1991-01-17 AT AT91100502T patent/ATE104349T1/de not_active IP Right Cessation
- 1991-01-23 CA CA002034768A patent/CA2034768A1/en not_active Abandoned
- 1991-01-23 HU HU91235A patent/HU211205B/hu not_active IP Right Cessation
- 1991-01-23 NZ NZ236864A patent/NZ236864A/xx unknown
- 1991-01-24 AU AU69952/91A patent/AU634335B2/en not_active Ceased
- 1991-01-24 JP JP3022573A patent/JP3023997B2/ja not_active Expired - Fee Related
- 1991-01-24 MC MC912167A patent/MC2227A1/xx unknown
- 1991-01-24 IL IL97013A patent/IL97013A/xx not_active IP Right Cessation
- 1991-01-24 NO NO910279A patent/NO303910B1/no not_active IP Right Cessation
- 1991-01-25 FI FI910398A patent/FI910398A/fi unknown
- 1991-01-25 PT PT96581A patent/PT96581B/pt not_active IP Right Cessation
- 1991-01-25 KR KR1019910001306A patent/KR100197455B1/ko not_active IP Right Cessation
- 1991-01-25 IE IE27691A patent/IE65363B1/en not_active IP Right Cessation
- 1991-01-25 YU YU12991A patent/YU48525B/sh unknown
- 1991-03-20 SA SA91110265A patent/SA91110265B1/ar unknown
-
1993
- 1993-03-24 HR HRP-129/91A patent/HRP930512B1/xx not_active IP Right Cessation
-
1998
- 1998-11-20 KR KR1019980049922A patent/KR100207354B1/ko not_active IP Right Cessation
-
1999
- 1999-11-19 JP JP33053299A patent/JP3215692B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2063383T3 (es) | Vacunas contra la coccidiosis. | |
DK289688A (da) | Ekspression af proapolipoprotein a-i. | |
ES2061520T3 (es) | Expresion de un antigeno especifico de tumor por un virus vector recombinante y utilizacion de este para el tratamiento preventivo o curativo del tumor correspondiente. | |
ES2127294T3 (es) | Vacunas del virus de la inmunodeficiencia anti-felino (fiv). | |
DE69225357T2 (de) | Impfstoff gegen Geflügelkokzidose | |
DK0491628T3 (da) | Lipopeptider inducerende cytotoksiske T-lymfocytter og deres anvendelse som vacciner | |
DE60237791D1 (de) | Zytokinproteinfamilie | |
DE69432137T2 (de) | Impfstoff gegen Geflügelkokzidose | |
EP0236977A3 (en) | Bovine virus diarrhea and hog cholera vaccines | |
ATE201446T1 (de) | Impfstoff gegen geflügelkokzidose | |
ATE136933T1 (de) | Rekombinante hbsag hybridpartikel, die morphologische eigenschaften von hbsag-antigen haben und eine immunogene sequenz enthalten, die neutralisierende antikörper gegen hiv induziert oder die von diesen antikörpern erkannt ist, nukleotide sequenzen, die diese partikel codieren und sie enthaltende impfstoffe | |
KR950700415A (ko) | 말라리아 백신(improvements in or relating to malaria vaccine) | |
DE59107665D1 (de) | Protektive Plasmodium falciparum Hybridproteine, die Teilsequenzen der Malaria-Antigene HRPII und SERP enthalten | |
DK43991D0 (da) | Allele varianter af plasmodium falciparum merozoitoverfladeantigen | |
GB2244273A (en) | Allelic variants of plasmodium falciparum merozoite surface antigen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 439056 Country of ref document: ES |